id 31
partner_person_id 419
sector_category_id 9
focus_type primary
weight_pct
source curated
confidence high
evidence_count
notes Bob Nelsen — biotech specialist
investor_fund_id
investor_company_id
tenant_id 1
created_at 2026-05-22T18:48:55.099106+00:00
updated_at 2026-06-06T00:51:27.495821+00:00
deal_book